000 | 01540 a2200445 4500 | ||
---|---|---|---|
005 | 20250512194329.0 | ||
264 | 0 | _c19850528 | |
008 | 198505s 0 0 eng d | ||
022 | _a0160-2446 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSchoenberger, J A | |
245 | 0 | 0 |
_aComparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension. _h[electronic resource] |
260 |
_bJournal of cardiovascular pharmacology _c1984 |
||
300 |
_aS1105-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
650 | 0 | 4 |
_aCalcium Channel Blockers _xadverse effects |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrochlorothiazide _xadverse effects |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNifedipine _xadverse effects |
650 | 0 | 4 | _aNitrendipine |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aGlasser, S P | |
700 | 1 | _aRam, C V | |
700 | 1 | _aMcMahon, S G | |
700 | 1 | _aVanov, S K | |
700 | 1 | _aLeibowitz, D A | |
773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 6 Suppl 7 _gp. S1105-8 |
|
999 |
_c6085493 _d6085493 |